The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Cyberonics Inc

Nasdaq: CYBX
Last

(U.S.) $55.56

Today's change+0.91 +1.67%
Updated December 19 4:00 PM EST. Delayed by at least 15 minutes.
 

Cyberonics Inc

Nasdaq: CYBX
Last

(U.S.) $55.56

Today's change+0.91 +1.67%
Updated December 19 4:00 PM EST. Delayed by at least 15 minutes.

Cyberonics Inc Hits New 20-day High

Cyberonics Inc closed up sharply Friday, rallying (U.S.)$0.91 or 1.67% to (U.S.)$55.56 and setting a new 20-day high. Over the last five days, shares have gained 3.35%, but are down 15.07% for the last year to date. Shares have underperformed the S&P 500 by 26.40% during the last year.

Key company metrics

  • Open(U.S.) $54.55
  • Previous close(U.S.) $54.65
  • High(U.S.) $55.92
  • Low(U.S.) $54.38
  • Bid / Ask-- / --
  • YTD % change-15.07%
  • Volume600,725
  • Average volume (10-day)429,023
  • Average volume (1-month)487,059
  • Average volume (3-month)377,449
  • 52-week range(U.S.) $48.19 to (U.S.) $73.52
  • Beta0.64
  • Trailing P/E23.79×
  • P/E 1 year forward23.07×
  • Forward PEG1.54×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.34
Updated December 19 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+21.88%

Based on its net profit margin of 21.88%, Cyberonics Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.85%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedOct 24, 201410/24/2014Jul 25, 201407/25/2014Apr 25, 201404/25/2014Jan 24, 201401/24/2014
Revenue73727568
Total other revenue--------
Total revenue73727568
Gross profit67666762
Total cost of revenue7676
Total operating expense47505147
Selling / general / administrative30333229
Research & development11111211
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--00--
Other operating expenses, total--------
Operating income26222321
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax26222321
Income after tax17141814
Income tax, total9957
Net income17141814
Total adjustments to net income--------
Net income before extra. items17141814
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items17141814
Inc. avail. to common incl. extra. items17141814
Diluted net income17141814
Dilution adjustment----00
Diluted weighted average shares27272727
Diluted EPS excluding extraordinary itemsvalue per share0.640.500.680.51
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.640.500.680.51